Caricamento...
Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells
Raloxifene hydrochloride (RAL), one of second generation of selective estrogen receptor modulators (SERMs), is usually used in preventing osteoporosis and breast cancer. The present study evaluated whether Raloxifene might sensitize multidrug resistant (MDR) breast cancers to chemotherapies, especia...
Salvato in:
| Pubblicato in: | Cancer Biol Ther |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847829/ https://ncbi.nlm.nih.gov/pubmed/26529585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1095409 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|